Calcitonin Salmon Recombinant Patent Expiration
Calcitonin Salmon Recombinant is Used for treating nasal conditions such as congestion or allergies.
It was first introduced by Upsher Smith Laboratories Llc
Calcitonin Salmon Recombinant Patents
Given below is the list of patents protecting Calcitonin Salmon Recombinant, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Fortical | US6440392 | Nasal calcitonin formulations |
Feb 02, 2021
(Expired) | Upsher Smith Labs |
| Fortical | USRE40812 | Nasal calcitonin formulation |
Feb 02, 2021
(Expired) | Upsher Smith Labs |
| Fortical | USRE43580 | Nasal calcitonin formulations |
Feb 02, 2021
(Expired) | Upsher Smith Labs |
Calcitonin Salmon Recombinant's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List